![[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!](https://businessfortnight.com/wp-content/uploads/2025/10/Toyota-Times-Century-as-a-Brand-Lexus-as-Innovation-All-218x150.jpg "[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!")
TOKYO and CAMBRIDGE, United Kingdom, Sept. 27, 2022 (GLOBE NEWSWIRE) — Sosei Group Corporation (“the Company”; TSE: 4565) will maintain an R&D Day on Thursday, 13 October 2022, at 3:30 pm JST. The assembly will probably be held in particular person in Tokyo for institutional buyers, securities analysts and the press and also will be obtainable by way of a reside webcast. Please click on right here to register for the occasion.
|
|
|
|
| Chris Cargill, President and CEO | |
| Corporate presentation, imaginative and prescient, technique and progress | |
| Matt Barnes, Head of UK R&D | |
| Focusing on out-licensed and partnered applications | |
| Rie Suzuki, Senior Director, Translational Biology | |
| Focused on wholly owned, in-house applications | |
About Sosei Heptares
We are a world biopharmaceutical group targeted on the invention and early growth of recent medicines originating from our proprietary GPCR-targeted StaR® know-how and structure-based drug design platform capabilities. We are advancing a broad and deep pipeline of novel medicines throughout a number of therapeutic areas, together with neurology, immunology, gastroenterology and inflammatory illnesses.
We have established partnerships with a few of the world’s main pharmaceutical firms and a number of rising know-how firms, together with AbbVie, AstraZeneca, Genentech (Roche), GSK, Kallyope, Neurocrine Biosciences, Novartis, Pfizer, Takeda and Verily. Sosei Heptares is headquartered in Tokyo, Japan with company and R&D amenities in Cambridge, UK.
“Sosei Heptares” is the company model and trademark of Sosei Group Corporation, which is listed on the Tokyo Stock Exchange (ticker: 4565). Sosei, Heptares, the brand and StaR® are emblems of Sosei Group firms.
For extra info, please go to https://www.soseiheptares.com/
LinkedIn: @soseiheptaresco | Twitter: @soseiheptaresco | YouTube: @soseiheptaresco
Enquiries:
Sosei Heptares – Media and Investor Relations
Hironoshin Nomura, Chief Financial Officer
Shinichiro Nishishita, VP Investor Relations, Head of Regulatory Disclosures
Candelle Chong, SVP Investor Relations and Corporate Strategy
Japan: +81 (0)3 5210 3399 | United Kingdom: +44 (0)1223 949390 | [email protected]
MEDiSTRAVA Consulting (for International Media)
Mark Swallow, Frazer Hall, Eleanor Perkin
+44 (0)203 928 6900 | [email protected]
![[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!](https://businessfortnight.com/wp-content/uploads/2025/10/Toyota-Times-Century-as-a-Brand-Lexus-as-Innovation-All-100x70.jpg "[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!")
